Wachtell Steers Perrigo In €275M Unit Sale To Pharma Biz
By Dawood Fakhir · April 25, 2024, 6:01 PM BST
Healthcare company Perrigo said Thursday that it has agreed to sell its pharmaceutical division for rare diseases to pharmaceutical company Esteve Healthcare SL for €275 million ($295 million) in a deal...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login